3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
10
Sarcoma
3
Other solid neoplasm
1
Genitourinary
1
Conditions
Carcinoma, Renal Cell
40
Kidney Neoplasms
30
Melanoma
25
Prostatic Neoplasms
24
Breast Neoplasms
18
Wilms Tumor
16
Neoplasm Metastasis
16
Ovarian Neoplasms
14
Carcinoma, Non-Small-Cell Lung
12
Testicular Neoplasms
11
Multiple Myeloma
11
Uterine Cervical Neoplasms
10
Sarcoma
9
Pancreatic Neoplasms
9
Neuroblastoma
9
Testicular Germ Cell Tumor
8
Lymphoma, Follicular
8
Lymphoma
8
Lung Neoplasms
8
Hodgkin Disease
8
Carcinoma, Hepatocellular
8
Triple Negative Breast Neoplasms
7
Neoplasms, Plasma Cell
7
Neoplasms
7
Lymphoma, Non-Hodgkin
7
Lymphoma, Mantle-Cell
7
Lymphoma, Large-Cell, Immunoblastic
7
Lymphoma, Large B-Cell, Diffuse
7
Leukemia, Myeloid, Acute
7
Leukemia, Lymphocytic, Chronic, B-Cell
7
Interventions
Thalidomide
2
omburtamab I-131
1
entinostat
1
carboxyamido-triazole
1
belzutifan
1
Radiotherapy, Image-Guided
1
Paclitaxel
1
Nivolumab
1
Genistein
1
Fentanyl
1
Erlotinib Hydrochloride
1
Docetaxel
1
Cyclophosphamide
1
CLR1404
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive
×
Cyclophosphamide
×
Genitourinary
×
Clear all
NCT01661400
2024-01-31
ASCR
Washington University School of Medicine
Phase 1
Completed
14 enrolled